These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37428562)

  • 1. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2.
    Liu Y; Chen M; Wu B
    Assay Drug Dev Technol; 2023 Jul; 21(5):202-211. PubMed ID: 37428562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
    Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
    J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression.
    Li X; Chen X; Fu C; Xie M; Ouyang S
    Chemotherapy; 2023; 68(3):119-130. PubMed ID: 36657426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1.
    Chen J; Wu Z; Deng W; Tang M; Wu L; Lin N; Chen L; Fu Y; Zhao M; Chen C; Li W
    J Transl Med; 2023 Jul; 21(1):453. PubMed ID: 37422632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor ELK3 Promotes Stemness and Oxaliplatin Resistance of Glioma Cells by Regulating RNASEH2A.
    Mei Y; Chen D; He S; Ye J; Luo M; Wu Q; Huang Y
    Horm Metab Res; 2023 Feb; 55(2):149-155. PubMed ID: 36638810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
    Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
    Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells.
    Liu G; Wang H; Ran R; Wang Y; Li Y
    Curr Med Chem; 2024; 31(22):3397-3411. PubMed ID: 38347785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
    Asadzadeh Z; Mansoori B; Mohammadi A; Kazemi T; Mokhtarzadeh A; Shanehbandi D; Hemmat N; Derakhshani A; Brunetti O; Safaei S; Aghajani M; Najafi S; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 May; 137():111364. PubMed ID: 33592546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
    Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
    J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
    Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X
    Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4.
    Deng J; Wang H; Liang Y; Zhao L; Li Y; Yan Y; Zhao H; Zhang X; Zou F
    Cell Signal; 2023 Jan; 101():110517. PubMed ID: 36332797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.